Cochlear Targets Niche Hearing Loss Markets With Nucleus Hybrid, PABI
This article was originally published in The Gray Sheet
Executive Summary
Cochlear Limited's Nucleus Hybrid cochlear implant will address the high-tonality hearing loss market not targeted by conventional implants and hearing aids, the firm says